Characteristics predictive of response to collagenase clostridium histolyticum for Peyronie’s disease: a review of the literature
Authors:
- 26 June 2019
- journal article
- review article
- Published by Springer Nature in World Journal of Urology
- Vol. 38 (2) , 279-285
Abstract
To evaluate characteristics predictive of successful treatment outcomes of Peyronie’s disease (PD) with collagenase clostridium histolyticum (CCH)Keywords
This publication has 14 references indexed in Scilit:
- Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie’s diseaseTranslational Andrology and Urology, 2017
- Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocolBJU International, 2017
- Impact of Number of Cycles of Collagenase Clostridium Histolyticum on Outcomes in Patients With Peyronie's DiseaseUrology, 2017
- Peyronie’s Disease: AUA GuidelineJournal of Urology, 2015
- Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double‐blind, randomized, placebo‐controlled, phase III studiesBJU International, 2015
- Peyronie’s Disease: A Review of Etiology, Diagnosis, and ManagementCurrent Sexual Health Reports, 2015
- PD48-06 OUTCOMES ASSOCIATED WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENT FOR PEYRONIE'S DISEASE BY DURATION OF DISEASEJournal of Urology, 2015
- Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 StudiesJournal of Urology, 2013
- An Analysis of the Natural History of Peyronie’s DiseaseJournal of Urology, 2006
- Collagenase Versus Placebo in the Treatment of Peyronie’s Disease: A Double-blind StudyJournal of Urology, 1993